860785898	860785898	CD	B-NP	O
|	|	NN	I-NP	O
TSH	TSH	NN	I-NP	O
|	|	NN	I-NP	O
35239455	35239455	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7528735	7528735	CD	B-NP	O
|	|	CC	I-NP	O
6/2/2005	6/2/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
FAILURE	FAILURE	NNP	I-NP	O
TO	TO	NNP	I-NP	O
THRIVE	THRIVE	NNP	I-NP	O
,	,	,	O	O
RENAL	RENAL	NNP	B-NP	O
FAILURE	FAILURE	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/30/2005	5/30/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/9/2005	4/9/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
ALTERMATT	ALTERMATT	NNP	B-NP	O
,	,	,	O	O
MARIO	MARIO	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Acute	Acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Acute	Acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
Right	Right	RB	B-NP	O
middle	middle	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
hematuria	hematuria	NN	B-NP	O
,	,	,	O	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
57-yeare-old	57-yeare-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
kidney	kidney	NN	I-NP	O
transplant	transplant	NN	I-NP	O
in	in	IN	B-PP	O
5/13	5/13	CD	B-NP	O
,	,	,	O	O
aortic	aortic	JJ	B-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
,	,	,	O	O
LIMA	LIMA	NN	B-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
,	,	,	O	O
in	in	IN	B-PP	O
7/7/005	7/7/005	CD	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
presenting	present	VBG	I-VP	O
here	here	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Otea	Otea	NNP	I-NP	O
Healthcare	Healthcare	NNP	I-NP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
urine	urine	NN	B-NP	O
output	output	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
creatinine	creatinine	NN	I-NP	O
from	from	IN	B-PP	O
3.3	3.3	CD	B-NP	O
the	the	DT	B-NP	O
baseline	baseline	NN	I-NP	O
to	to	TO	B-PP	O
5.3	5.3	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
report	report	VB	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
felt	feel	VBD	B-VP	O
worse	worse	JJR	B-ADJP	O
than	than	IN	B-SBAR	O
he	he	PRP	B-NP	O
normally	normally	RB	B-ADVP	O
feels	feel	VBZ	B-VP	O
at	at	IN	B-PP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
developed	develop	VBN	I-VP	O
some	some	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
his	his	PRP$	B-NP	B-DNA
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
described	describe	VBD	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
cough	cough	NN	I-NP	O
with	with	IN	B-PP	O
whitish	whitish	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
blood	blood	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denied	deny	VBD	B-VP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
did	do	VBD	B-VP	O
report	report	NN	B-NP	O
being	be	VBG	B-VP	O
short	short	RB	B-ADVP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
while	while	IN	B-SBAR	O
lying	lie	VBG	B-VP	O
flat	flat	JJ	B-ADJP	O
,	,	,	O	O
or	or	CC	O	O
orthopnea	orthopnea	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
describe	describe	VB	I-VP	O
any	any	DT	B-NP	O
PND	PND	NN	I-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
reported	report	VBD	B-VP	O
a	a	DT	B-NP	O
fever	fever	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
chills	chill	NNS	I-NP	O
and	and	CC	I-NP	O
sweats	sweat	NNS	I-NP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
before	before	IN	B-PP	O
being	be	VBG	B-VP	O
presented	present	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
described	describe	VBD	B-VP	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	I-NP	O
dysuria	dysuria	NN	I-NP	O
x2	x2	NN	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
nausea	nausea	NN	I-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
or	or	CC	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
palpitations	palpitation	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
aortic	aortic	JJ	B-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
in	in	IN	B-PP	O
6/24	6/24	CD	B-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
buttock	buttock	NN	B-NP	O
ulcer	ulcer	NN	I-NP	O
,	,	,	O	O
also	also	RB	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Plastic	Plastic	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
type	type	NN	I-NP	O
II	II	CD	I-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Included	Include	VBN	B-VP	O
CellCept	CellCept	NNP	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
valacyclovir	valacyclovir	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
calcitriol	calcitriol	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mcg	mcg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
metoprolol	metoprolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Bactrim	Bactrim	NNP	B-NP	O
single	single	JJ	I-NP	O
strength	strength	NN	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
16	16	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
q.a.m.	q.a.m.	RB	B-ADVP	O
,	,	,	O	O
18	18	CD	B-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
NovoLog	NovoLog	NNP	B-NP	O
6	6	CD	I-NP	O
units	unit	NNS	I-NP	O
q.a.c.	q.a.c.	RB	B-ADVP	O
with	with	IN	B-PP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
tramadol	tramadol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
ALLERGIES	ALLERGIES	NNS	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
reports	report	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
temperature	temperature	NN	I-NP	O
was	be	VBD	B-VP	O
97.7	97.7	CD	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
93-97	93-97	CD	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
respiratory	respiratory	JJ	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
30s	30	NNS	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
167/90	167/90	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
O2	O2	NN	I-NP	O
saturation	saturation	NN	I-NP	O
was	be	VBD	B-VP	O
97-99	97-99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
fairly	fairly	RB	B-NP	O
significant	significant	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
difficulty	difficulty	NN	B-NP	O
catching	catch	VBG	B-VP	O
his	his	PRP$	B-NP	O
breath	breath	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
head	head	NN	I-NP	O
and	and	CC	I-NP	O
neck	neck	NN	I-NP	O
exam	exam	NN	I-NP	O
is	be	VBZ	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
pupils	pupil	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
cervical	cervical	JJ	I-NP	O
lymphedema	lymphedema	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
icterus	icterus	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
about	about	IN	B-NP	O
12	12	CD	I-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
carotid	carotid	JJ	I-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
rate	rate	NN	B-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
regular	regular	JJ	B-ADJP	O
at	at	IN	B-PP	O
2/6	2/6	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
and	and	CC	O	O
heard	hear	VBD	B-VP	O
best	good	JJS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
S3	S3	NN	B-NP	B-protein
or	or	CC	I-NP	O
S4	S4	NN	I-NP	B-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
chest	chest	NN	I-NP	O
incision	incision	NN	I-NP	O
was	be	VBD	B-VP	O
clean	clean	JJ	B-ADJP	O
,	,	,	I-ADJP	O
dry	dry	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
crackles	crackle	NNS	B-NP	O
bilaterally	bilaterally	RB	B-PP	O
about	about	RB	B-NP	O
a	a	DT	I-NP	O
halfway	halfway	NN	I-NP	O
up	up	RP	B-PRT	O
his	his	PRP$	B-NP	O
back	back	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
nondistended	nondistended	JJ	B-ADJP	O
,	,	,	O	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Incision	Incision	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
was	be	VBD	B-VP	O
similarly	similarly	RB	B-ADJP	O
clean	clean	JJ	I-ADJP	O
,	,	,	I-ADJP	O
dry	dry	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
were	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
3-4	3-4	CD	B-NP	O
+	+	SYM	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
significant	significant	JJ	B-NP	O
pitting	pitting	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
thighs	thigh	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
some	some	DT	B-NP	O
dependent	dependent	JJ	I-NP	O
decubitus	decubitus	NN	I-NP	O
edema	edema	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	B-protein
had	have	VBD	B-VP	I-protein
2	2	CD	B-NP	I-protein
+	+	SYM	B-NP	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
fistula	fistula	NN	I-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
arm	arm	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
decubitus	decubitus	NN	I-NP	O
sacral	sacral	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
VAC	VAC	NN	I-NP	O
dressing	dress	VBG	B-VP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
cranial	cranial	JJ	I-NP	O
nerves	nerve	NNS	I-NP	O
were	be	VBD	B-VP	O
all	all	DT	O	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
focal	focal	JJ	I-NP	O
deficits	deficit	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
Ischemia	Ischemia	NNP	B-NP	O
:	:	:	O	O
Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
and	and	CC	I-NP	O
AVR	AVR	NN	I-NP	B-protein
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
held	hold	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
biopsy	biopsy	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
kidney	kidney	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
continued	continue	VBD	B-VP	O
his	his	PRP$	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
at	at	IN	B-PP	O
b.i.d.	b.i.d.	JJ	B-NP	O
dosing	dosing	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
four-beat	four-beat	JJ	B-NP	O
runs	run	NNS	I-NP	O
of	of	IN	B-PP	O
NSVT	NSVT	NN	B-NP	B-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
repeat	repeat	VB	I-VP	O
after	after	IN	B-PP	O
repletion	repletion	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
again	again	RB	B-ADVP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
3	3	CD	I-NP	O
overnight	overnight	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
chest	chest	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Lopressor	Lopressor	NNP	B-NP	O
x1	x1	CD	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
once	once	RB	B-ADVP	O
again	again	RB	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
developed	develop	VBN	I-VP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
likely	likely	RB	B-ADJP	O
incisional	incisional	JJ	I-ADJP	O
and	and	CC	O	O
not	not	RB	B-ADJP	O
cardiac	cardiac	JJ	I-ADJP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
exam	exam	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
acute	acute	JJ	B-NP	O
worsening	worsening	NN	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
status	status	NN	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
observation	observation	NN	I-NP	O
area	area	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
increasing	increase	VBG	I-NP	O
O2	O2	NN	I-NP	O
requirement	requirement	NN	I-NP	O
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
diuresing	diurese	VBG	I-VP	O
effectively	effectively	RB	B-ADVP	O
with	with	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
360	360	CD	I-NP	O
mg	mg	NN	I-NP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
to	to	TO	B-PP	O
him	him	PRP	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
Renal	Renal	NNP	B-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
urgently	urgently	RB	B-ADVP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
him	him	PRP	B-NP	O
in	in	IN	B-PP	O
observation	observation	NN	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
for	for	IN	B-PP	O
urgent	urgent	JJ	B-NP	O
dialysis	dialysis	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
,	,	,	O	O
they	they	PRP	B-NP	O
removed	remove	VBD	B-VP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
4	4	CD	I-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
symptomatically	symptomatically	RB	I-VP	O
improved	improve	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
post-dialysis	post-dialysis	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
oxygen	oxygen	NN	I-NP	O
requirement	requirement	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
nasal	nasal	JJ	I-NP	O
cannula	cannula	NN	I-NP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
his	his	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
x1	x1	NN	I-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
4	4	CD	I-NP	O
with	with	IN	B-PP	O
excellent	excellent	JJ	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
improved	improve	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
after	after	IN	B-PP	O
hospital	hospital	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
5.3	5.3	CD	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
peaked	peak	VBD	B-VP	O
at	at	IN	B-PP	O
6.6	6.6	CD	B-NP	O
and	and	CC	O	O
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
5.1	5.1	CD	B-NP	O
with	with	IN	B-PP	O
clear	clear	JJ	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
improvement	improvement	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
with	with	IN	B-PP	O
large	large	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
IV	IV	NNP	B-NP	O
Lasix	Lasix	NNP	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
Renal	Renal	NNP	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
to	to	TO	I-VP	O
clarify	clarify	VB	I-VP	O
whether	whether	IN	B-SBAR	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
acute	acute	JJ	I-NP	O
rejection	rejection	NN	I-NP	O
versus	versus	IN	B-PP	O
ATN	ATN	NN	B-NP	B-protein
from	from	IN	B-PP	O
toxic	toxic	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
cyclosporin	cyclosporin	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
one	one	CD	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Solu-Medrol	Solu-Medrol	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
elevated	elevate	VBN	I-VP	O
cyclosporin	cyclosporin	NN	B-NP	O
levels	level	NNS	I-NP	O
at	at	IN	B-PP	O
679	679	CD	B-NP	O
,	,	,	O	O
so	so	RB	B-ADVP	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
likely	likely	JJ	I-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
cyclosporin	cyclosporin	NN	I-NP	O
was	be	VBD	B-VP	O
temporarily	temporarily	RB	I-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
cyclosporin	cyclosporin	NN	I-NP	O
levels	level	NNS	I-NP	O
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
point	point	NN	I-NP	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
just	just	RB	B-ADVP	O
slightly	slightly	RB	I-ADVP	O
over	over	IN	B-PP	O
100	100	CD	B-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
3	3	CD	I-NP	O
and	and	CC	O	O
cyclosporin	cyclosporin	NN	B-NP	O
was	be	VBD	B-VP	O
reinitiated	reinitiate	VBN	I-VP	O
at	at	IN	B-PP	O
lower	low	JJR	B-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
dialyzed	dialyze	VBN	I-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
removal	removal	NN	B-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
,	,	,	O	O
CVM	CVM	NN	B-NP	B-protein
,	,	,	O	O
BK	BK	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
LDH	LDH	NN	B-NP	B-protein
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
from	from	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
improved	improve	VBD	B-VP	O
,	,	,	O	O
so	so	RB	O	O
further	further	JJ	B-NP	O
dialysis	dialysis	NN	I-NP	O
and	and	CC	I-NP	O
biopsy	biopsy	NN	I-NP	O
were	be	VBD	B-VP	O
deemed	deem	VBN	I-VP	O
unnecessary	unnecessary	JJ	B-ADJP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
status	status	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
UTI	UTI	NN	B-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	B-protein
500	500	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
x1	x1	NN	I-NP	I-protein
and	and	CC	O	O
then	then	RB	O	O
250	250	CD	B-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
48h	48h	NN	I-NP	O
.	.	.	O	O

for	for	IN	B-PP	O
a	a	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
grew	grow	VBD	B-VP	O
4/4	4/4	CD	B-NP	O
Gram-negative	Gram-negative	JJ	I-NP	O
rods	rod	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
urosepsis	urosepsis	NN	B-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
daily	daily	JJ	I-NP	O
and	and	CC	O	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
q.4-8h	q.4-8h	NN	I-NP	O
.	.	.	O	O

Transplant	Transplant	NN	B-NP	O
and	and	CC	I-NP	O
Infectious	Infectious	JJ	I-NP	O
Disease	Disease	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
who	who	WP	B-NP	O
recommended	recommend	VBD	B-VP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
be	be	VB	B-VP	O
discontinued	discontinue	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
with	with	IN	B-PP	O
repeat	repeat	NN	B-NP	O
cultures	culture	NNS	I-NP	O
.	.	.	O	O

HSV	HSV	NN	B-NP	O
swap	swap	NN	I-NP	O
from	from	IN	B-PP	O
sacral	sacral	JJ	B-NP	O
wound	wound	NN	I-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
.	.	.	O	O

These	These	DT	B-NP	O
repeat	repeat	NN	I-NP	O
cultures	culture	NNS	I-NP	O
and	and	CC	O	O
HSV	HSV	NN	B-NP	B-protein
swab	swab	NN	I-NP	I-protein
were	be	VBD	B-VP	O
all	all	DT	O	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
levofloxacin	levofloxacin	NN	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
postdischarge	postdischarge	VBP	B-VP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
We	We	PRP	B-NP	O
held	hold	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
fluids	fluid	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
checked	check	VBD	B-VP	O
his	his	PRP$	B-NP	B-DNA
I	I	NN	I-NP	I-DNA
's	's	POS	B-NP	O
and	and	CC	O	O
O	O	NNP	B-NP	O
's	's	POS	B-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
daily	daily	JJ	I-NP	O
basis	basis	NN	I-NP	O
with	with	IN	B-PP	O
daily	daily	JJ	B-NP	O
weights	weight	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
hyperkalemia	hyperkalemia	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
6.1	6.1	CD	B-NP	O
,	,	,	O	O
resolved	resolve	VBN	B-VP	O
with	with	IN	B-PP	O
Kayexalate	Kayexalate	NN	B-NP	O
,	,	,	I-NP	O
insulin	insulin	NN	I-NP	B-protein
and	and	CC	I-NP	O
D50	D50	NN	I-NP	O
meds	med	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
additional	additional	JJ	B-NP	O
Kayexalate	Kayexalate	NNP	I-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
came	come	VBD	B-VP	O
up	up	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	B-DNA
K	K	NN	I-NP	I-DNA
resolved	resolve	VBD	B-VP	O
,	,	,	O	O
backed	back	VBD	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
normal	normal	JJ	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
renal	renal	JJ	I-NP	O
and	and	CC	I-NP	O
cardiac	cardiac	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
albumin	albumin	NN	I-NP	O
and	and	CC	O	O
total	total	JJ	B-NP	O
protein	protein	NN	I-NP	O
were	be	VBD	B-VP	O
low	low	JJ	B-ADJP	O
,	,	,	O	O
so	so	IN	O	O
a	a	DT	B-NP	O
nutritional	nutritional	JJ	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
optimized	optimize	VBD	B-VP	O
his	his	PRP$	B-NP	O
nutritional	nutritional	JJ	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
tight	tight	JJ	I-NP	O
glycemic	glycemic	JJ	I-NP	O
control	control	NN	I-NP	O
on	on	IN	B-PP	O
NPH	NPH	NN	B-NP	O
16	16	CD	I-NP	O
units	unit	NNS	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
19	19	CD	B-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
NovoLog	NovoLog	NNP	B-NP	O
6	6	CD	I-NP	O
units	unit	NNS	I-NP	O
q.a.c.	q.a.c.	RB	B-ADVP	O
with	with	IN	B-PP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
sacral	sacral	JJ	I-NP	O
decubitus	decubitus	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
VAC	VAC	NN	I-NP	O
dressing	dress	VBG	B-VP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Plastics	Plastic	NNS	B-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
to	to	TO	B-VP	O
address	address	VB	I-VP	O
his	his	PRP$	B-NP	O
VAC	VAC	NN	I-NP	B-protein
.	.	.	O	O

They	They	PRP	B-NP	O
took	take	VBD	B-VP	O
down	down	RP	B-PRT	O
the	the	DT	B-NP	O
VAC	VAC	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
some	some	DT	B-NP	O
leakage	leakage	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
1/4	1/4	CD	O	O
Dakin	Dakin	NNP	B-NP	O
's	's	POS	B-NP	O
solution	solution	NN	I-NP	O
and	and	CC	I-NP	O
wet-to-dry	wet-to-dry	JJ	I-NP	O
dressing	dress	VBG	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
continued	continue	VBD	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
wet-to-dry	wet-to-dry	JJ	I-NP	O
dressings	dressing	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
VNA	VNA	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
the	the	DT	B-NP	O
VAC	VAC	NN	I-NP	O
replaced	replace	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
VNA	VNA	NN	I-NP	B-protein
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
on	on	IN	B-PP	O
Nexium	Nexium	NN	B-NP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
and	and	CC	O	O
we	we	PRP	B-NP	O
held	hold	VBD	B-VP	O
his	his	PRP$	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
biopsy	biopsy	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
resume	resume	VB	I-VP	O
his	his	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
and	and	CC	O	O
INR	INR	NN	B-NP	O
checks	check	NNS	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
INR	INR	NNP	I-NP	O
Follow-Up	Follow-Up	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
leave	leave	VB	I-VP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
for	for	IN	B-PP	O
cigarettes	cigarette	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
signed	sign	VBD	B-VP	O
an	an	DT	B-NP	O
agreement	agreement	NN	I-NP	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
going	go	VBG	I-VP	O
to	to	TO	I-VP	O
tolerate	tolerate	VB	I-VP	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
leaving	leave	VBG	B-VP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
for	for	IN	B-PP	O
short	short	JJ	B-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
time	time	NN	B-NP	O
even	even	RB	B-PP	O
while	while	IN	I-PP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
included	include	VBD	B-VP	O
calcitriol	calcitriol	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
16	16	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
q.a.m.	q.a.m.	RB	B-ADVP	O
,	,	,	O	O
18	18	CD	B-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	NN	B-NP	O
,	,	,	O	O
ketoconazole	ketoconazole	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
,	,	,	O	O
cyclosporin	cyclosporin	NN	B-NP	O
125	125	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
tramadol	tramadol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	NN	B-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
Bactrim	Bactrim	NNP	B-NP	O
single	single	JJ	I-NP	O
strength	strength	NN	I-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
CellCept	CellCept	NNP	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
valacyclovir	valacyclovir	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	B-protein
250	250	CD	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
every	every	DT	B-NP	I-protein
other	other	JJ	I-NP	I-protein
day	day	NN	I-NP	I-protein
x2	x2	NN	I-NP	I-protein
weeks	week	NNS	I-NP	I-protein
,	,	,	O	O
NovoLog	NovoLog	NNP	B-NP	O
6	6	CD	I-NP	O
units	unit	NNS	I-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
,	,	,	O	O
Neoral	Neoral	NNP	B-NP	O
125	125	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
in	in	IN	B-PP	O
stale	stale	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
3-5245631	3-5245631	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
CLANCY	CLANCY	NN	B-NP	O
,	,	,	O	O
JACOB	JACOB	NNP	B-NP	B-protein
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
RAMEY	RAMEY	NN	B-NP	O
,	,	,	O	O
GAYLE	GAYLE	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
2973351	2973351	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
7/9/05	7/9/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
7/9/05	7/9/05	CD	B-NP	O

